Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QR059349 in paroxysmal nocturnal hemoglobinuria with active hemolysis
CTR20243319Phase 2Active
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd.
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of QR059349 in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Wuhan Createrna Science and Technology Co., Ltd.. Started Nov 2024; status: active.
02
Drugs
QR059349
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on CTR20243319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243319.